DURHAM, N.C.–(BUSINESS WIRE)– #EHR–Sightview’s new UI brings workflow and efficiency enhancements, developed and tested with optometrists, ophthalmologists and opticians.
National Vision Launches 2025-2026 Scholarship Program, Spotlighting Technology’s Role in Access to Eye Care
DULUTH, Ga.–(BUSINESS WIRE)–National Vision Holdings, Inc. (NASDAQ: EYE), one of the largest optical retail companies in the United States, announced today that its annual scholarship program is open for entries, offering eligible optometry students …
Uncategorized
EyeDura Initiates Preclinical Efficacy Studies to Advance Insulin-Based Treatment for Neurotrophic Keratitis
NEW YORK–(BUSINESS WIRE)–EyeDura Initiates Preclinical Efficacy Studies to Advance Insulin-Based Treatment for Neurotrophic Keratitis
Uncategorized
Violet light filters in IOLs may reduce dysphotopsias
Patients implanted with the Tecnis Symfony OptiBlue IOL, which includes a violet light filter, reported fewer dysphotopsias at 1 month vs. those implanted with the Tecnis Symfony IOL, which includes an ultraviolet light filter.“Extended depth of focus …
Uncategorized
Yunqi Capital, One of STAAR Surgical Company’s Largest Shareholders, Reiterates Its Opposition to the Proposed Merger with Alcon
HONG KONG–(BUSINESS WIRE)–Yunqi Capital Limited (together with its affiliates and the funds it advises, “Yunqi Capital”), an investment management firm and 5.1% shareholder of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ:STAA), today rel…
Fuchs Endothelial Corneal Dystrophy Market Report 2025-2035: Epidemiology, Regulatory Landscape, Ongoing Clinical Trials, Market Dynamics, Patent Analysis – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Fuchs Endothelial Corneal Dystrophy Market – A Global and Regional Analysis: Focus on Treatment Method, End User, and Region – Analysis and Forecast, 2025-2035” report has been added to ResearchAndMarkets.com’s offering. T…